Skip to main content
Trending
Nordic defenseChildhood obesityMonetary policyTax strategyCollege affordabilityFood chemistryDomestic deploymentBundesliga historyDrug discoverySearch algorithmsCivic lotteriesCarbon marketsStellar physicsSteamos expansionGrid expansionTranslated fictionDeli supply chainThermal managementHappiness psychologyLabor economicsCivil procedureBuilding scienceDietary restraintManga publishingValuation standardsStatistical modelingRemote work dynamicsFoldable hardwareHealth benefitsEu governance

Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Explainer

The Mechanism of Ultra-Processed Foods: Why Industrial Diets Drive a 25% Higher Risk of Metabolic Syndrome

6 sources · 56d ago

Testosterone Therapy

FDA Signals End to Restrictions on Testosterone Therapy for Age-Related Low T After Removing Black Box Warning

3 sources · 56d ago

Explainer

Landmark Approval: First Drug Proven to Cut Acute Pancreatitis Risk in Severe Hypertriglyceridemia

4 sources · 56d ago

More in Health

ExplainerProstate Cancer

Landmark Trial: Perioperative Apalutamide Improves Metastasis-Free Survival in Localized High-Risk Prostate Cancer

Clinical Investigators 45%Surgical Urologists 35%Pharmaceutical Developers 20%

5 sources · 56d ago

Research BriefPsychedelic Medicine

Psilocybin Completes Second Pivotal Phase 3 Trial, Paving Way for FDA Review in Depression

Clinical Researchers 41%Regulatory Pragmatists 35%Healthcare Economists 24%

5 sources · 56d ago

Regenerative MedicineClinical Milestone

First-in-Human Trial Shows Stem Cell Transplant for Parkinson's Disease is Feasible and Safe

Regenerative Medicine Researchers 45%Biotech and Industry Developers 30%Patient Advocacy Organizations 25%

3 sources · 57d ago

ExplainerPsychiatric Medicine

First New Class of Schizophrenia Drug in Decades Targets Muscarinic Receptors, Halving Symptoms

Clinical Psychiatrists 40%Patient Advocates 35%Neuropharmacologists 25%

4 sources · 57d ago

Dental ImagingTech Breakthrough

FDA Clears First-Ever Dental-Dedicated MRI for Non-Ionizing Soft-Tissue Diagnostics

Diagnostic Innovators 45%Clinical Specialists 40%Healthcare Economists 15%

4 sources · 57d ago

Precision OncologyExplainer

Landmark Trial: Combination of Talazoparib and Enzalutamide Halves Progression Risk in Metastatic Prostate Cancer

Clinical Oncologists 40%Precision Medicine Advocates 30%Patient Quality-of-Life Researchers 30%

4 sources · 57d ago

ExplainerOncology Breakthrough

Landmark Trial Cracks 'Undruggable' KRAS Target, Delivering Unprecedented Survival Advantage in Pancreatic Cancer

Targeted Therapy Advocates 45%Structural Biologists 30%Access & Policy Watchdogs 25%

7 sources · 57d ago

Peptide RegulationExplainer

The Evidence Pack: How an Imminent FDA Hearing Will Decide the Fate of BPC-157 and TB-500

Biohackers & Longevity Advocates 40%Regulatory & Safety Officials 35%Compounding Pharmacists 25%

2 sources · 57d ago

Epigenetic ReprogrammingClinical Trial

First Human Trial of Cellular Reprogramming Drug Begins, Targeting Age Reversal in the Optic Nerve

Longevity Biotech Advocates 45%Clinical Ophthalmologists 35%Safety & Regulatory Monitors 20%

3 sources · 57d ago

Research BriefLongevity Medicine

Landmark $38M Trial Tests Rapamycin, GLP-1, and SGLT2 Inhibitors as First Longevity Drugs in Healthy Adults

Geroscience Innovators 45%Clinical Evidence Pragmatists 35%Regulatory & Safety Watchdogs 20%

4 sources · 57d ago

ExplainerFood Chemical Safety

The Evidence Pack: How the FDA's New Chemical Safety Mandate is Targeting Phthalates, BHA, and the GRAS Loophole

Regulatory & Academic Scientists 41%Public Health Advocates 29%Food Industry & Manufacturers 29%

3 sources · 58d ago

Research BriefCare Integration

Landmark Study: Integrating Suicide Care Into Routine Primary Care Slashes Attempt Rates by 25%

Clinical Researchers 40%Primary Care Providers 35%Patient Advocacy Groups 25%

5 sources · 58d ago

Obesity MedicineTrial Results

Eli Lilly's Triple-Hormone Agonist Retatrutide Achieves 28% Weight Loss in Phase 3 Trial

Clinical Researchers 41%Industry Analysts 35%Patient Advocates 24%

3 sources · 58d ago

ExplainerNeurotherapeutics

Landmark Research: Non-Hallucinogenic 'Psychoplastogen' Molecules Retain Therapeutic Effect for Depression and Anxiety

Neuroplasticity Researchers 40%Clinical Development & Industry 40%Independent Clinical Analysts 20%

4 sources · 58d ago

Blindspot

Important stories the mainstream barely covered

High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.

All blindspots →
environment

Europe's Record Heatwave Blamed for Over 30,000 Deaths as Crisis Spreads Across Continent

A relentless sequence of heatwaves across Europe has claimed tens of thousands of lives this summer, overwhelming public health infrastructure and forcing a continent-wide reckoning with climate adaptation.

Public Health Officials 40%Climate Scientists 40%Urban Resilience Planners 20%

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy